Smithfield Trust CO Astrazeneca PLC Transaction History

Smithfield Trust CO

$2.01 Billion
Q4 2024

A detailed history of Smithfield Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Smithfield Trust CO holds 4,148 shares of AZN stock, worth $298,614. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,148

Previous 4,619 10.2%

Holding current value

$298,614

Previous $358,000 24.3%

% of portfolio

0.01%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$63.2 - $79.58 $29,767 - $37,482	-471 Reduced 10.2%	4,148 $271,000
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $36,111 - $41,269	471 Added 11.35%	4,619 $358,000
Q2 2024 Jul 31, 2024	SELL	$66.81 - $80.83 $2,806 - $3,394	-42 Reduced 1.0%	4,148 $322,000
Q1 2024 May 07, 2024	SELL	$61.03 - $69.57 $1,159 - $1,321	-19 Reduced 0.45%	4,190 $285,000
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $47,162 - $61,282	-870 Reduced 17.13%	4,209 $286,000
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $65,267 - $167,108	-1,231 Reduced 19.51%	5,079 $278,000
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $120,712 - $144,912	2,037 Added 47.67%	6,310 $419,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $8,302 - $10,000	-149 Reduced 3.37%	4,273 $285,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $756 - $893	-14 Reduced 0.32%	4,422 $256,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $21,501 - $23,525	387 Added 9.56%	4,436 $264,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $28,626 - $33,045	607 Added 17.64%	4,049 $201,000
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $100,096 - $119,695	-2,063 Reduced 37.48%	3,442 $173,000
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $4,245 - $4,888	-80 Reduced 1.43%	5,505 $302,000
Q1 2020 May 05, 2020	SELL	$37.79 - $51.33 $3,967 - $5,389	-105 Reduced 1.85%	5,585 $249,000
Q4 2019 Feb 13, 2020	SELL	$42.46 - $50.46 $16,389 - $19,477	-386 Reduced 6.35%	5,690 $284,000
Q3 2019 Oct 30, 2019	BUY	$40.12 - $45.47 $66,398 - $75,252	1,655 Added 37.43%	6,076 $271,000
Q2 2019 Aug 06, 2019	BUY	$37.28 - $41.68 $8,313 - $9,294	223 Added 5.31%	4,421 $182,000
Q4 2018 Feb 04, 2019	BUY	$36.86 - $41.49 $109,105 - $122,810	2,960 Added 239.1%	4,198 $160,000
Q1 2018 May 10, 2018	SELL	$32.97 - $36.63 $2,967 - $3,296	-90 Reduced 6.78%	1,238 $43,000
Q3 2017 Nov 03, 2017	BUY	$28.96 - $34.0 $38,458 - $45,152	1,328	1,328 $45,000

Others Institutions Holding AZN

# of Institutions

1,350

Shares Held

477M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $223B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.

Account

Smithfield Trust CO Astrazeneca PLC Transaction History